Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia
AssigneeKissei Pharmaceutical Co., Ltd.
InventorsMamoru Kobayashi, Satoshi Murata, Yoshimi Tsukahara
Life of this patent
Estimating the term…
Loading patent…
AssigneeKissei Pharmaceutical Co., Ltd.
InventorsMamoru Kobayashi, Satoshi Murata, Yoshimi Tsukahara
Estimating the term…
The present invention provides agents for the prevention or treatment of intrauterine growth retardation or gestational toxicosis comprising as an active ingredient phenylethanolaminotetralin derivatives represented by the formula (I) or pharmaceutically acceptable salts thereof such as a sulfate salt thereof, which exert a remarkable improving effect on fetal weight loss and static gangrene in the tip of fetal extremities and a remarkable improving effect on elevation of maternal urinary protein and plasma triglyceride level with ease of anxiety on palpitation of dams or the like. Examples of administration forms include, for example, tablets, capsules, injections and so on. As diseases to be treated, for example, asymmetrical intrauterine growth retardation and hyperlipidemia associated with gestational toxicosis are specially preferable.
An agent for the prevention or treatment of intrauterine growth retardation or gestational toxicosis, characterized by comprising as an active ingredient a phenylethanolaminotetralin derivative represented by the general formula:
Dependencies are inferred from the claim text.